Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9252458rdf:typepubmed:Citationlld:pubmed
pubmed-article:9252458lifeskim:mentionsumls-concept:C1257792lld:lifeskim
pubmed-article:9252458lifeskim:mentionsumls-concept:C0243127lld:lifeskim
pubmed-article:9252458lifeskim:mentionsumls-concept:C1442080lld:lifeskim
pubmed-article:9252458lifeskim:mentionsumls-concept:C0443331lld:lifeskim
pubmed-article:9252458pubmed:issue1 Pt 1lld:pubmed
pubmed-article:9252458pubmed:dateCreated1997-9-3lld:pubmed
pubmed-article:9252458pubmed:abstractTextTwo noninvasive methods, calorimetry and 31P nuclear magnetic resonance (NMR), were used to further define energy-consuming and energy-providing reactions in endothelial cells. With 31P-NMR, cellular ATP content was measured; with calorimetry, heat flux as a result of ATP turnover was measured. For these measurements, pig aortic endothelial cells were cultured on microcarrier beads and perfused in a column at constant flow rate. Pig aortic endothelial cells synthesize ATP mainly through glycolysis and, as determined by NMR, contain no phosphocreatine. In such a system, calorimetry-measured heat flux reflects rate of cellular ATP turnover. By use of inhibitors of ATP-dependent processes, the following changes in basal heat flux (231 +/- 65.5 microW/mg protein) were obtained: 18% for 2,3-butanedione monoxime (inhibitor of actomyosin-ATPase), 17% for wortmannin (inhibitor of myosin light chain kinase), 10% for cytochalasin D (inhibitor of actin polymerization), 23% for cycloheximide (inhibitor of protein synthesis), 11% for thapsigargin (inhibitor of endoplasmic reticulum Ca(2+)-ATPase), and 6% for bafilomycin A1 (inhibitor of lysosomal H(+)-ATPase). Cytochalasin D, 2,3-butanedione monoxime, wortmannin, and thapsigargin caused changes in F-actin distribution, as revealed by rhodamine-phalloidin cytochemistry. In a separate experimental series, when cells were perfused with a medium containing no glucose, heat flux decreased by 40% while cellular ATP remained unchanged. Inhibition of glycolysis with 2-deoxy-D-glucose decreased heat flux by 73%, and ATP was no longer visible with 31P-NMR. Despite this massive ATP depletion, which was maintained for 3 h, cells fully recovered heat flux and ATP when 2-deoxy-D-glucose was removed. The results, together with previously published data for Na(+)-K(+)-ATPase [M. L. H. Gruwel, C. Alves, and J. Schrader. Am. J. Physiol. 268 (Heart Circ. Physiol. 37): H351-H358, 1995], demonstrate that > 70% of total ATP-consuming processes of endothelial cells can be attributed to specific cellular processes. Actomyosin-ATPase (18%) and protein synthesis (23%) comprise the largest fraction. At least three-fourths of ATP synthesized is provided by glycolysis. Endothelial cells exhibit the remarkable ability to coordinate downregulation of ATP synthesis and consumption when glycolysis is inhibited.lld:pubmed
pubmed-article:9252458pubmed:languageenglld:pubmed
pubmed-article:9252458pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9252458pubmed:citationSubsetIMlld:pubmed
pubmed-article:9252458pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9252458pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9252458pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9252458pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9252458pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9252458pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9252458pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9252458pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9252458pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9252458pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9252458pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9252458pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9252458pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9252458pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9252458pubmed:statusMEDLINElld:pubmed
pubmed-article:9252458pubmed:monthJullld:pubmed
pubmed-article:9252458pubmed:issn0002-9513lld:pubmed
pubmed-article:9252458pubmed:authorpubmed-author:SchraderJJlld:pubmed
pubmed-article:9252458pubmed:authorpubmed-author:CulicOOlld:pubmed
pubmed-article:9252458pubmed:authorpubmed-author:GruwelM LMLlld:pubmed
pubmed-article:9252458pubmed:issnTypePrintlld:pubmed
pubmed-article:9252458pubmed:volume273lld:pubmed
pubmed-article:9252458pubmed:ownerNLMlld:pubmed
pubmed-article:9252458pubmed:authorsCompleteYlld:pubmed
pubmed-article:9252458pubmed:paginationC205-13lld:pubmed
pubmed-article:9252458pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:9252458pubmed:meshHeadingpubmed-meshheading:9252458-...lld:pubmed
pubmed-article:9252458pubmed:meshHeadingpubmed-meshheading:9252458-...lld:pubmed
pubmed-article:9252458pubmed:meshHeadingpubmed-meshheading:9252458-...lld:pubmed
pubmed-article:9252458pubmed:meshHeadingpubmed-meshheading:9252458-...lld:pubmed
pubmed-article:9252458pubmed:meshHeadingpubmed-meshheading:9252458-...lld:pubmed
pubmed-article:9252458pubmed:meshHeadingpubmed-meshheading:9252458-...lld:pubmed
pubmed-article:9252458pubmed:meshHeadingpubmed-meshheading:9252458-...lld:pubmed
pubmed-article:9252458pubmed:meshHeadingpubmed-meshheading:9252458-...lld:pubmed
pubmed-article:9252458pubmed:meshHeadingpubmed-meshheading:9252458-...lld:pubmed
pubmed-article:9252458pubmed:meshHeadingpubmed-meshheading:9252458-...lld:pubmed
pubmed-article:9252458pubmed:meshHeadingpubmed-meshheading:9252458-...lld:pubmed
pubmed-article:9252458pubmed:meshHeadingpubmed-meshheading:9252458-...lld:pubmed
pubmed-article:9252458pubmed:meshHeadingpubmed-meshheading:9252458-...lld:pubmed
pubmed-article:9252458pubmed:meshHeadingpubmed-meshheading:9252458-...lld:pubmed
pubmed-article:9252458pubmed:meshHeadingpubmed-meshheading:9252458-...lld:pubmed
pubmed-article:9252458pubmed:meshHeadingpubmed-meshheading:9252458-...lld:pubmed
pubmed-article:9252458pubmed:meshHeadingpubmed-meshheading:9252458-...lld:pubmed
pubmed-article:9252458pubmed:meshHeadingpubmed-meshheading:9252458-...lld:pubmed
pubmed-article:9252458pubmed:meshHeadingpubmed-meshheading:9252458-...lld:pubmed
pubmed-article:9252458pubmed:meshHeadingpubmed-meshheading:9252458-...lld:pubmed
pubmed-article:9252458pubmed:meshHeadingpubmed-meshheading:9252458-...lld:pubmed
pubmed-article:9252458pubmed:year1997lld:pubmed
pubmed-article:9252458pubmed:articleTitleEnergy turnover of vascular endothelial cells.lld:pubmed
pubmed-article:9252458pubmed:affiliationInstitut für Herz- und Kreislaufphysiologie, Heinrich Heine Universität Düsseldorf, Germany.lld:pubmed
pubmed-article:9252458pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9252458pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9252458lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9252458lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9252458lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9252458lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9252458lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9252458lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9252458lld:pubmed